Biofilms are formations that occur when a group of microorganisms such as bacteria, fungi, parasites and viruses attach themselves to a surface and create a colony. These biofilms form themselves into a type of ‘shield’ that has a glue-like consistency, often referred to as ‘slime’.
SIBO causes inflammation both in the gut and systemically and is notoriously difficult to treat, with high relapse rates, so finding new treatment protocols for SIBO is hugely beneficial.
Saccharomyces boulardii is a well-researched immunobiotic, which has been shown to restore intestinal integrity and potentially reduce pathogenic gut microbiota.
It is estimated that the global prevalence of IBS is 11%. The most common cause of IBS is small intestinal bacterial overgrowth (SIBO) — in fact, a whopping 60-80% of IBS is due to this common condition, totalling a possible 500 million people worldwide.